Target intelligence / Profile preview

Intestinal epithelial tight junction complex (TJ complex) (TJ complex)

Target
TJ complex
Molecular classification
Protein complex, Cell-cell junction, Other
01

Overview

The intestinal epithelial tight junction (TJ) complex is a highly specialized multi-protein structure located at the apical-most part of the lateral intercellular space between adjacent epithelial cells (StatPearls, 2023). It functions as a primary semi-permeable barrier, regulating the paracellular movement of ions, water, and solutes while restricting the passage of harmful pathogens and environmental antigens (PubMed, PMID: 21248165). The complex consists of transmembrane proteins, including claudins, occludin, and junctional adhesion molecules (JAMs), which interact with intracellular scaffold proteins like zonula occludens (ZO-1, ZO-2, ZO-3) to link the junction to the actin cytoskeleton (UniProt, P15151). Dysfunction or "leakiness" of this complex is a critical factor in the pathogenesis of various gastrointestinal and systemic disorders, such as Crohn's disease, celiac disease, and type 1 diabetes (PubMed, PMID: 22109896). Therapeutic interventions, such as larazotide acetate, aim to stabilize the TJ complex or inhibit the zonulin pathway to restore barrier integrity and reduce inflammation (ClinicalTrials.gov, NCT03573258). Monitoring the integrity of this complex is often achieved through biomarkers like serum zonulin levels or the lactulose/mannitol ratio (PubMed, PMID: 21248165).

Other names
Zonula occludensTight junctionOccluding junctionIntercellular junctional complex
02

Mechanism of action

Tight junction modulation, Zonulin antagonism, Regulation of claudin and occludin expression

03

Biological functions

Barrier functionParacellular transport regulationSignal transductionImmune responseOther
04

Disease associations

Inflammatory bowel diseaseCeliac diseaseInflammationInfectionOther
05

Safety considerations

Increased systemic exposure to luminal antigensElectrolyte imbalancePotential for non-specific permeability in other epithelial barriers
06

Interacting drugs

Larazotide acetate

4 more in the full profile.

07

Biomarkers

Serum zonulinLactulose/Mannitol ratioTransepithelial electrical resistance (TEER)Claudin-3 expression

Beyond the preview

Go deeper on Intestinal epithelial tight junction complex (TJ complex) (TJ complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial tight junction complex (TJ complex) (TJ complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call